Importance of PET with 68Ga-Labeled Somatostatin Analogs (perspective on “68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT” J Nucl Med. 2007;48:508–518)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.